INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 30 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -50.0% | 4,255 | -0.9% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 4,295 | -0.8% | 0.00% | – |
| Q2 2019 | $4,000 | -42.9% | 4,329 | -9.1% | 0.00% | – |
| Q1 2019 | $7,000 | -12.5% | 4,763 | -8.8% | 0.00% | – |
| Q4 2018 | $8,000 | -33.3% | 5,220 | -13.2% | 0.00% | – |
| Q3 2018 | $12,000 | -7.7% | 6,017 | -22.9% | 0.00% | – |
| Q2 2018 | $13,000 | – | 7,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|